News About: Pharm. Industry
Cha Bio & Disotech eyes foreign hospital
Cha Bio & Diostech is negotiating with a foreign hospital for a possible takeover.
However, the company refused to elaborate on the takeover in its regulatory filing on Thursday, saying it will make public after th...
Orient Bio breaks ground for new transplant research center
Orient Bio Inc., which operates in the biotechnology business here, broke ground on Tuesday to set up a new organ transplant research center in Seongnam City, Gyeonggi Province.
The company announced that it plans ...
Big drug companies boosting R&D spending
Leading pharmaceutical companies have been spending more on research and development (R&D) projects to strengthen their technology leadership.
According to Yakup.com, a pharmaceutical information portal, Hanmi Phar...
Korea to join international pharmaceutical regulatory group
Korea applied for a membership of the Pharmaceutical Inspection Convention and Cooperation Scheme (PIC/S), an international forum for the exchange of regulatory information about pharmaceutical products, in April, acc...
Yuyu to boost vitamin C brand through e-gaming
E-gaming, also known as e-sports, is relatively unknown to the general public but is followed zealously by gamers and tech savvy people.
Yuyu Pharmaceutical has recently decided to sponsor Star Tale, one of Korea’s...
Drugmakers’ worst performance will likely rekindling of kickbacks
The country’s pharmaceutical companies including top-tier ones have struggled to find their feet during the first half, even after a government-mandated price cut came into effect last year.
They are still feeling ...
HanAll Biopharma release more affordable drug for pulmonary hypertension
HanAll Biopharma said Tuesday that it will soon launch a more affordable locally-produced sildenafil product ‘Pahdenafil 20 mg tablets’ for the treatment of pulmonary hypertension.
The retail price is set at 1,000 ...
Dong-A Pharmaceutical to market new reflux esophagitis drugDong-A Pharmaceutical announced Tuesday that it has started distributing over-the-counter drug Acinon solution through pharmacies.
The new product, which contains sodium algi...
|
DreamPharma wins approval for world-first incrementally modified drug
A local pharmaceutical company has won approval to produce the world’s first incrementally modified drug (IMD), paving the way for it to enter a new market with lucrative potential.
DreamPharma, an affiliated comp...
Therapeutic potential of GV1001 analyzed in international scientific journal
A flurry of articles were published on GV1001, a pancreatic cancer treatment developed Korea-based developer KAEL-GemVax.
Recently, the results of CPP (cell-penetrating peptide) related study on GV1001 was publishe...
